Strategies for improving expression of recombinant human chorionic gonadotropin in Chinese Hamster Ovary (CHO) cells

被引:1
作者
Boukari, Iheb [1 ,2 ]
Rourou, Samia
Bouzazi, Dorsaf [4 ]
Essafi-Benkhadir, Khadija [3 ]
Kallel, Hela [1 ,5 ]
机构
[1] Univ Tunis Manar, Inst Pasteur Tunis, Lab Mol Microbiol Vaccinol & Biotechnol Dev, LR16IPT01,Biotechnol Dev Grp, Tunis 1002, Tunisia
[2] Carthage Univ, Fac Sci Bizerte, Bizerte 7021, Tunisia
[3] Univ Tunis El Manar, Inst Pasteur Tunis, Lab Mol Epidemiol & Expt Pathol, LR16IPT04, Tunis 1002, Tunisia
[4] Univ Tunis Manar, Inst Pasteur Tunis, Plateforme Physiol & Physiopathol Cardiovasc, Tunis 1002, Tunisia
[5] Univercells SA, Gosselies, Belgium
关键词
CHO cells; Human chorionic gonadotropin; Signal peptide; Stable pool. bioprocess optimization; SIGNAL PEPTIDE; PROTEIN EXPRESSION; OPTIMIZATION; GLYCOSYLATION; SECRETION; SEQUENCE; HORMONE;
D O I
10.1016/j.pep.2024.106596
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
Optimizations of the gene expression cassette combined with the selection of an appropriate signal peptide are important factors that must be considered to enhance heterologous protein expression in Chinese Hamster Ovary (CHO) cells. In this study, we investigated the effectiveness of different signal peptides on the production of recombinant human chorionic gonadotropin (r-hCG) in CHO-K1 cells. Four optimized expression constructs containing four promising signal peptides were stably transfected into CHO-K1 cells. The generated CHO-K1 stable pool was then evaluated for r-hCG protein production. Interestingly, human serum albumin and human interleukin-2 signal peptides exhibited relatively greater extracellular secretion of the r-hCG with an average yield of (16.59 +/- 0.02 mu g/ml) and (14.80 +/- 0.13 mu g/ml) respectively compared to the native and murine IgGx light chain signal peptides. The stably transfected CHO pool was further used as the cell substrate to develop an optimized upstream process followed by a downstream phase of the r-hCG. Finally, the biological activity of the purified r-hCG was assessed using in vitro bioassays. The combined data highlight that the choice of signal peptide can be imperative to ensure an optimal secretion of a recombinant protein in CHO cells. In addition, the stable pool technology was a viable approach for the production of biologically active r-hCG at a research scale with acceptable bioprocess performances and consistent product quality.
引用
收藏
页数:10
相关论文
共 48 条
  • [41] WIREN KM, 1988, J BIOL CHEM, V263, P19771
  • [42] Advances and Practices of Bioprocess Scale-up
    Xia, Jianye
    Wang, Guan
    Lin, Jihan
    Wang, Yonghong
    Chu, Ju
    Zhuang, Yingping
    Zhang, Siliang
    [J]. BIOREACTOR ENGINEERING RESEARCH AND INDUSTRIAL APPLICATIONS II, 2016, 152 : 137 - 151
  • [43] Progress in fed-batch culture for recombinant protein production in CHO cells
    Xu, Wen-Jing
    Lin, Yan
    Mi, Chun-Liu
    Pang, Jing-Ying
    Wang, Tian-Yun
    [J]. APPLIED MICROBIOLOGY AND BIOTECHNOLOGY, 2023, 107 (04) : 1063 - 1075
  • [44] Rapid Protein Production Using CHO Stable Transfection Pools
    Ye, Jianxin
    Alvin, Krista
    Latif, Haythem
    Hsu, Amy
    Parikh, Vanessa
    Whitmer, Travis
    Tellers, Melanie
    Edmonds, M. Celina de la Cruz
    Ly, Jeffrey
    Salmon, Peter
    Markusen, Julia F.
    [J]. BIOTECHNOLOGY PROGRESS, 2010, 26 (05) : 1431 - 1437
  • [45] Zhang JY, 2010, MANUAL OF INDUSTRIAL MICROBIOLOGY AND BIOTECHNOLOGY, THIRD EDITION, P157
  • [46] Alteration in the IL-2 signal peptide affects secretion of proteins in vitro and in vivo
    Zhang, L
    Leng, QX
    Mixson, AJ
    [J]. JOURNAL OF GENE MEDICINE, 2005, 7 (03) : 354 - 365
  • [47] Mammalian cell protein expression for biopharmaceutical production
    Zhu, Jianwei
    [J]. BIOTECHNOLOGY ADVANCES, 2012, 30 (05) : 1158 - 1170
  • [48] Characterization of human chorionic gonadotropin as a novel angiogenic factor
    Zygmunt, M
    Herr, F
    Keller-Schoenwetter, S
    Kunzi-Rapp, K
    Münstedt, K
    Rao, CV
    Lang, U
    Preissner, KT
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2002, 87 (11) : 5290 - 5296